Mandeep Kaur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mandeep Kaur has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Preeti Khetarpal
Department of Human Genetics and Molecular Medicine, Central University of Punjab, Bathinda, India
4 shared publications Kiran Chhabra
2 shared publications- Rajinder Kaur
Department Of Human Genetics, Punjabi University, Patiala, Punjab, India
2 shared publications - Ahelee Ghosal
Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India
1 shared publication Harmanpreet Singh Kapoor
1 shared publication- Harmanpreet Singh Kapoor
Department of Mathematics and Statistics, Central University of Punjab, Bathinda, India
1 shared publication
Latest Publications
- 8 January 2025
- Published by Elsevier in Gene Reports
- Vol. 38
Investigation of MTHFR, NR5A1 gene polymorphisms in association with infertility in couples: A case-control and in silico study
- 8 January 2025
- Published by Elsevier in Gene Reports
- Vol. 38
Investigation of MTHFR, NR5A1 gene polymorphisms in association with infertility in couples: A case-control and in silico study
- 28 March 2024
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 53 (6) , 102782
Exposure to potentially toxic elements (PTEs) and the risk of male infertility- A Systematic review and meta-analysis
- 28 March 2024
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 53 (6) , 102782
Exposure to potentially toxic elements (PTEs) and the risk of male infertility- A Systematic review and meta-analysis
- 1 March 2023
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 162 (3) , 829-841
Maternal candidate gene variants, epigenetic factors, and susceptibility to idiopathic recurrent pregnancy loss: A systematic review
Background: Recurrent pregnancy loss is defined as the loss of two or more pregnancies and is a distressing condition for couples.Objective: To investigate the relationship between variants in the candidate susceptibility genes and epigenetic factors to identify risk factors for idiopathic recurrent pregnancy loss (iRPL).Search Strategy: A systematic literature search was performed using PubMed, Google Scholar, ScienceDirect, and Scopus databases. Insilico analysis was carried out using ShinyGO and STRING software.Selection Criteria: Research papers examining the association between variations in genetic and epigenetic factors and iRPL.Data Collection and Analysis: Data were independently extracted by two authors.Main Results: In total, 83 research papers were finally selected for the present study. Among all the genes involved in the pathogenesis of recurrent pregnancy loss, polymorphisms in IL superfamily genes, VEGF, ESR, and MTHFR were the most investigated.Conclusion: Polymorphisms in angiogenesis, immune tolerance, and thrombophilia pathway genes, which occur independently or synergistically, may lead to various complications during fetal development. Identification of multi‐allele risk variants and epigenetic factors in women will be helpful in the identification of high‐risk pregnancies.Prospero Registration Number: Prospero CRD42021287315.
- 1 March 2023
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 162 (3) , 829-841
Maternal candidate gene variants, epigenetic factors, and susceptibility to idiopathic recurrent pregnancy loss: A systematic review
Background: Recurrent pregnancy loss is defined as the loss of two or more pregnancies and is a distressing condition for couples.Objective: To investigate the relationship between variants in the candidate susceptibility genes and epigenetic factors to identify risk factors for idiopathic recurrent pregnancy loss (iRPL).Search Strategy: A systematic literature search was performed using PubMed, Google Scholar, ScienceDirect, and Scopus databases. Insilico analysis was carried out using ShinyGO and STRING software.Selection Criteria: Research papers examining the association between variations in genetic and epigenetic factors and iRPL.Data Collection and Analysis: Data were independently extracted by two authors.Main Results: In total, 83 research papers were finally selected for the present study. Among all the genes involved in the pathogenesis of recurrent pregnancy loss, polymorphisms in IL superfamily genes, VEGF, ESR, and MTHFR were the most investigated.Conclusion: Polymorphisms in angiogenesis, immune tolerance, and thrombophilia pathway genes, which occur independently or synergistically, may lead to various complications during fetal development. Identification of multi‐allele risk variants and epigenetic factors in women will be helpful in the identification of high‐risk pregnancies.Prospero Registration Number: Prospero CRD42021287315.
- 27 August 2021
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 43 (3) , 349-358
A cross-sectional study on prevalence of menstrual problems, lifestyle, mental health, and PCOS awareness among rural and urban population of Punjab, India
Menstrual cycle gets affected by various modifiable risk factors. To assess prevalence of various types of menstrual problems, lifestyle and mental health status, identification of variables as pre...
- 27 August 2021
- Published by Taylor & Francis in Journal of Psychosomatic Obstetrics & Gynecology
- Vol. 43 (3) , 349-358
A cross-sectional study on prevalence of menstrual problems, lifestyle, mental health, and PCOS awareness among rural and urban population of Punjab, India
Menstrual cycle gets affected by various modifiable risk factors. To assess prevalence of various types of menstrual problems, lifestyle and mental health status, identification of variables as pre...
- 1 August 2013
- Published by Jaypee Brothers Medical Publishing in International Journal of Infertility & Fetal Medicine
- Vol. 4 (2) , 45-55
Diminished Ovarian Reserve, Causes, Assessment and Management
Diminished ovarian reserve predicts diminished ovarian response to stimulation but does not predict cycle fecundity. It has been recently defined by ESHRE, the Bologna's criteria, according to which at least two of the following three features should be present: (1) Age >40 years/any other risk factor for DOR, (2) abnormal ovarian reserve test, i.e. antral follicle count, AMH, (3) poor ovarian response in a previous stimulated cycle, i.e. less than three follicles after standard gonadotropin stimulation. Poor response to maximal stimulation on two previous occasions also defines DOR.The treatment options are limited. Avoiding the GnRH agonist long protocol and stimulation with microdose flare or antagonist protocol yields better results. Adjuvant therapy with LH, DHEAS and growth hormone shows some benefit in improving the oocyte yield. It is advisable to perform ICSI for all obtained oocytes and some advocate assisted hatching. Pregnancy rates are, however, poor and often these patients require ovum donation. Developing tests that will diagnose DOR in a low-risk population will allow women to plan their reproductive careers early.How to cite this article: Kaur M, Arora M. Diminished Ovarian Reserve, Causes, Assessment and Management. Int J Infertility Fetal Med 2013;4(2):45-55.
- 1 August 2013
- Published by Jaypee Brothers Medical Publishing in International Journal of Infertility & Fetal Medicine
- Vol. 4 (2) , 45-55
Diminished Ovarian Reserve, Causes, Assessment and Management
Diminished ovarian reserve predicts diminished ovarian response to stimulation but does not predict cycle fecundity. It has been recently defined by ESHRE, the Bologna's criteria, according to which at least two of the following three features should be present: (1) Age >40 years/any other risk factor for DOR, (2) abnormal ovarian reserve test, i.e. antral follicle count, AMH, (3) poor ovarian response in a previous stimulated cycle, i.e. less than three follicles after standard gonadotropin stimulation. Poor response to maximal stimulation on two previous occasions also defines DOR.The treatment options are limited. Avoiding the GnRH agonist long protocol and stimulation with microdose flare or antagonist protocol yields better results. Adjuvant therapy with LH, DHEAS and growth hormone shows some benefit in improving the oocyte yield. It is advisable to perform ICSI for all obtained oocytes and some advocate assisted hatching. Pregnancy rates are, however, poor and often these patients require ovum donation. Developing tests that will diagnose DOR in a low-risk population will allow women to plan their reproductive careers early.How to cite this article: Kaur M, Arora M. Diminished Ovarian Reserve, Causes, Assessment and Management. Int J Infertility Fetal Med 2013;4(2):45-55.